Medicated Skin Care in Romania

Publication Date	September 2009
Publisher	Euromonitor
Product Type	Report
Pages	36
ISBN Number	not applicable
Product Code	EUR00364

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Medicated Skin Care in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage:

market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the medicated skin care industry
Identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

Medicated Skin Care in Romania
Euromonitor International
September 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
- Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
- Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
- Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
- Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
- Table 5 Medicated Skin Care Company Shares by Value 2004-2008
- Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
- Table 7 Acne Treatments Brand Shares by Value 2005-2008
- Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
- Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
- Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
Antibiotice SA
Strategic Direction
Key Facts
- Summary 1 Antibiotice SA: Key Facts
- Summary 2 Antibiotice SA: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary 3 Antibiotice SA: Competitive Position 2008
Biofarm SA
Strategic Direction
Key Facts
- Summary 4 Biofarm SA: Key Facts
- Summary 5 Biofarm SA: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary 6 Biofarm SA: Competitive Position 2008
Ozone Laboratories SRL
Strategic Direction
Key Facts
- Summary 7 Ozone Laboratories SRL: Key Facts
- Summary 8 Ozone Laboratories SRL: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary 9 Ozone Laboratories SRL: Competitive Position 2008
Terapia Ranbaxy
Strategic Direction
Key Facts
- Summary 10 Terapia Ranbaxy: Key Facts
- Summary 11 Terapia Ranbaxy: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary 12 Terapia Ranbaxy: Competitive Position 2008
Zentiva SA
Strategic Direction
Key Facts
- Summary 13 Zentiva SA: Key Facts
- Summary 14 Zentiva SA: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary 15 Zentiva SA: Competitive Position 2008
Executive Summary
Excellent Dynamics in 2008
Increased Purchasing Power Sustains Growth
Domestic Producers Lead the Market
Chemists/pharmacies Maintains Its Dominance
Changing Lifestyles Increase OTC Consumption
Key Trends and Developments
Ageing Population Drives Market Performance
Growing Incomes Stimulate Self-medication
OTC Healthcare Remains Highly Regulated
Modernisation of Pharmacies Contributes To Sales Growth
Domestic Producers Lead the Market
Rural Areas Represent Strong Growth Potential
Market Indicators
- Table 11 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 12 Life Expectancy at Birth 2003-2008
Market Data
- Table 13 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 14 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 15 OTC Healthcare Company Shares by Value 2004-2008
- Table 16 OTC Healthcare Brand Shares by Value 2005-2008
- Table 17 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 18 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 19 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 20 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
- Summary 16 OTC Healthcare Switches 2005-2008
Definitions
- Summary 17 Research Sources